These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11428239)

  • 21. Validation of self-reported pneumococcal vaccination in behavioral risk factor surveillance surveys: experience from the sickness prevention achieved through regional collaboration (SPARC) program.
    Shenson D; Dimartino D; Bolen J; Campbell M; Lu PJ; Singleton JA
    Vaccine; 2005 Jan; 23(8):1015-20. PubMed ID: 15620474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccination with the pneumococcal 7-valent conjugate: a successful experiment but the species is adapting.
    Beall B
    Expert Rev Vaccines; 2007 Jun; 6(3):297-300. PubMed ID: 17542743
    [No Abstract]   [Full Text] [Related]  

  • 23. Antibiotic prevention of pneumococcal infections in asplenic hosts: admission of insufficiency.
    de Montalembert M; Lenoir G
    Ann Hematol; 2004 Jan; 83(1):18-21. PubMed ID: 14534810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention and management of pneumococcal disease.
    King L; Burns J
    Nurs Stand; 2001 Nov 14-20; 16(9):49-54; quiz 54-6. PubMed ID: 11974810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The public health ramifications of pneumococcal resistance.
    Reinert RR
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():1-3. PubMed ID: 19366361
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy of pneumococcal vaccination on chronic lymphocytic leukemia: should we rely on surrogate markers?
    Sinisalo M; Vilpo J; Itälä M; Väkeväinen M; Taurio J; Aittoniemi J
    Vaccine; 2008 Jul; 26(32):3959. PubMed ID: 18514977
    [No Abstract]   [Full Text] [Related]  

  • 27. Effectiveness of pneumococcal vaccination for elderly people in Catalonia, Spain: a case-control study.
    Dominguez A; Salleras L; Fedson DS; Izquierdo C; Ruiz L; Ciruela P; Fenoll A; Casal J
    Clin Infect Dis; 2005 May; 40(9):1250-7. PubMed ID: 15825026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. National paediatric immunization program of high risk groups: no effect on the incidence of invasive pneumococcal diseases.
    Rendi-Wagner P; Paulke-Korinek M; Kundi M; Burgmann H; Georgopoulos A; Vécsei A; Kollaritsch H
    Vaccine; 2009 Jun; 27(30):3963-8. PubMed ID: 19393711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HHS-CDC news: Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--US, 1998-2003.
    Ann Pharmacother; 2005 Nov; 39(11):1967-8. PubMed ID: 16219891
    [No Abstract]   [Full Text] [Related]  

  • 30. Expected benefits of pneumococcal vaccination in Canadian infants and children < 5 years old.
    Can Commun Dis Rep; 2006 Mar; 32(5):45-54. PubMed ID: 16649291
    [No Abstract]   [Full Text] [Related]  

  • 31. [Is pneumococcal conjugate vaccine needed?].
    Nuorti P
    Duodecim; 2002; 118(1):77-9. PubMed ID: 12229003
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pharmaco-economic aspects of vaccination against invasive pneumococcal infections in persons over 65 years of age; review of the literature on cost effectiveness analysis].
    Postma MJ; Heijnen ML; Beutels P; Jager JC
    Ned Tijdschr Geneeskd; 2002 May; 146(18):855-9. PubMed ID: 12038224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pneumococcal disease and emergence of serotypes in the vaccine era. Transient trends and serotype replacement?].
    Moraga-Llop FA
    Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):1-4. PubMed ID: 19217995
    [No Abstract]   [Full Text] [Related]  

  • 34. [Disribution of Streptococcus pneumoniae serotypes and serogroups among patients with invasive pneumococcal diseases in the Czech Republic in 1996-2003: background data for vaccination strategy].
    Motlová J
    Epidemiol Mikrobiol Imunol; 2005 Feb; 54(1):3-10. PubMed ID: 15807381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pneumococcal vaccination for persons 65 years of age and older].
    van den Bosch WJ
    Ned Tijdschr Geneeskd; 2002 May; 146(18):838-9. PubMed ID: 12038219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Splenectomy and pneumococcal vaccination].
    van Haecht CH
    Ned Tijdschr Geneeskd; 2003 Jun; 147(23):1141. PubMed ID: 12822526
    [No Abstract]   [Full Text] [Related]  

  • 37. Universal pneumococcal vaccination for India.
    Mathew JL
    Indian Pediatr; 2008 Feb; 45(2):160-1. PubMed ID: 18310801
    [No Abstract]   [Full Text] [Related]  

  • 38. Adults with invasive pneumococcal disease: missed opportunities for vaccination.
    Kyaw MH; Greene CM; Schaffner W; Ray SM; Shapiro M; Barrett NL; Gershman K; Craig AS; Roberson A; Zell ER; Schuchat A; Bennett NM; Whitney CG;
    Am J Prev Med; 2006 Oct; 31(4):286-92. PubMed ID: 16979452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experience with pneumococcal conjugate vaccine in Norway.
    Aaberge IS
    Expert Rev Vaccines; 2009 Feb; 8(2):159-65. PubMed ID: 19196196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Has the seven-valent pneumococcal conjugate vaccine had an impact on invasive pneumococcal disease in Western Australia?
    Giele C; Moore H; Bayley K; Harrison C; Murphy D; Rooney K; Keil AD; Lehmann D
    Vaccine; 2007 Mar; 25(13):2379-84. PubMed ID: 17064825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.